Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates
Around 3 in every 1,000 babies can have a brain injury during birth due to a lack of oxygen. Cooling therapy helps reduce this injury, but it can be painful for the baby. Hospitals usually give morphine for this pain. This study is testing a new medicine called dexmedetomidine, which has shown promise in smaller studies. Dexmedetomidine might not only relieve pain but also help reduce inflammation, speed up recovery, and shorten hospital stays. This research aims to see if dexmedetomidine is better than morphine for managing pain during cooling therapy and if it improves long-term health for these babies. It will also look at how parents experience this challenging time.
At a glance
What is this study about?
When some babies have a tough start in life, like an injury to their brain from not getting enough oxygen during birth, doctors sometimes use a special treatment called cooling therapy. This involves gently lowering the baby's body temperature for about three days. It's a proven way to protect the baby's brain from further damage and can reduce problems later in life, such as difficulties with movement or learning as they grow up.
However, being cooled can be uncomfortable for babies, causing them pain, shivering, and stress. To help with this, babies are usually given pain relief medication like morphine. Researchers are now looking at another medicine called dexmedetomidine. Early studies suggest it might be safe and could offer extra benefits beyond just pain relief. It might help reduce swelling in the brain, help babies recover faster, and even mean they spend less time in the hospital.
This study is a step towards understanding if dexmedetomidine is a better option than morphine for these babies. It will help doctors decide which medicine is best for keeping babies comfortable during cooling therapy and for giving them the best chance for a healthy future. The study will also look at how parents feel during this difficult time and how babies develop over the first year.
Key takeaways
- Cooling therapy helps protect baby brains after birth injury.
- This study compares two pain relief medicines: morphine (standard) and dexmedetomidine (new).
- Dexmedetomidine might offer extra benefits like faster recovery.
- Researchers will check short-term health and development at one year.
- Participation involves observation during standard care, with no extra tests.
Who may be eligible?
This study is looking for very specific newborn babies. Your baby might be able to take part if they were born at or after 35 weeks of pregnancy and weighed at least 2.5 kilograms (about 5 pounds, 8 ounces). They also need to show signs of having a difficult start, like low oxygen levels in their blood around the time of birth, which then led to signs of brain injury.
Crucially, your baby would need to start cooling therapy within 8 hours of being born to be considered for this study. The medical team would need to get your permission to join the study within 20 hours after your baby's birth.
However, your baby would not be able to participate if they have certain conditions that were known before birth, such as major brain problems, significant genetic conditions, or certain muscle and nerve disorders. The study is open to both baby boys and baby girls who meet the criteria.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Was your baby born at or after 35 weeks of pregnancy?
- Did your baby weigh at least 2.5 kilograms (about 5 pounds, 8 ounces) at birth?
- Did your baby show signs of brain injury due to low oxygen around birth?
- Did your baby start cooling therapy within 8 hours of being born?
- Does your baby NOT have major brain, genetic, or muscle disorders known before birth?
What does participation involve?
If your baby takes part in this study, they will receive either dexmedetomidine or morphine through an IV drip during their cooling therapy, just like current standard care. Doctors and nurses will carefully monitor your baby's comfort levels, vital signs, and overall health throughout the cooling process and their hospital stay. They will also look for any side effects from the medication. The study will mainly involve observing your baby and collecting information from their routine medical care. There might be some extra questionnaires for parents about their experiences. Researchers will also follow up on your baby's development at about one year of age to see how they are progressing.
Potential risks and benefits
Locations (1)
- McMaster Children's HospitalVerified postcodeHamilton, Canada
Common questions
What is cooling therapy?
Cooling therapy is a special treatment where a baby's body temperature is gently lowered for about three days to help protect their brain after a lack of oxygen during birth.
What is dexmedetomidine?
Dexmedetomidine is a medicine that helps with pain and sedation. It's being studied to see if it's better than morphine during cooling therapy for babies, possibly offering extra benefits like reducing swelling.
Will my baby get extra tests?
No, your baby will not have additional medical tests just for this study. All observations and information will come from their standard medical care.
How long does the study last?
The main part of the study involves your baby's time in the hospital during cooling therapy. There will also be a follow-up check on their development when they are about one year old.
What if I change my mind?
You can decide to withdraw your baby from the study at any time, and this will not affect the medical care they receive.
How to find out more
IPSITA GOSWAMI, MD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.